Nykode Therapeutics AS (OSL:NYKD)
Norway flag Norway · Delayed Price · Currency is NOK
1.660
+0.018 (1.10%)
Jun 3, 2025, 4:25 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Novel Vaccines and Immunotherapies
136.38M
Log In
Log In
Log In
Log In
Upgrade
Novel Vaccines and Immunotherapies Growth
97.76%
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical
-
Log In
Log In
Log In
Log In
Upgrade
Biopharmaceutical Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
136.38M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
97.76%
Log In
Log In
Log In
Log In
Upgrade
Norway
-
Log In
Log In
Log In
Log In
Upgrade
Norway Growth
-
Log In
Log In
Log In
Log In
Upgrade